| Entry |
|
|---|
| Name |
Oxcarbazepine (USAN/INN);
Trileptal (TN) |
|---|
| Formula |
C15H12N2O2
|
|---|
| Mass |
252.0899 |
|---|
| Structure |
     |
|---|
| Target |
voltage-gated sodium channel (SCN1A) blocker [HSA:6323];
voltage-gated sodium channel (SCN2A) blocker [HSA:6326];
voltage-gated sodium channel (SCN3A) blocker [HSA:6328];
voltage-gated sodium channel (SCN4A) blocker [HSA:6329];
voltage-gated sodium channel (SCN5A) blocker [HSA:6331];
voltage-gated sodium channel (SCN8A) blocker [HSA:6334];
voltage-gated sodium channel (SCN9A) blocker [HSA:6335] |
|---|
| Activity |
Anticonvulsant;
Antiepileptic |
|---|
| Remark |
Same as: C07492
ATC code: N03AF02
 |
|---|
| Pathway |
PATH: ko00982 Drug metabolism - cytochrome P450
PATH: map07033 Anticonvulsants |
|---|
| Other DBs |
CAS: 28721-07-5
PubChem: 7847599
DrugBank: DB00776
LigandBox: D00533
NIKKAJI: J21.258J |
|---|
| KCF data |
 |
|---|
